Showing 205–213 of 213 resultsSorted by latest
Pharma & Biotech
MedTech Worldwide sales of $7.5bn increased to 10% with growth of 11.6%(adjusted operational sales grew to 6%) in the U.S. and 8.3% outside of the U.S, driven primarily by electrophysiology products in Interventional Solutions and Abiomed contributed 4.6% to operational growth.
The company achieved an impressive 9% operational revenue growth.
LLY operates as a drug manufacturer and has been successful in developing a number of important drugs for diseases like cancer, diabetes and COVID-19.
The global pharmacy environment has been impacted by labor shortages and changing regulatory requirements.
TWST is the developer of synthetic DNA-based products which is experiencing high demand. These products are being used widely in healthcare industry for sequencing and research.
